92.JPG)
The Therapeutic Proteins and Oral Vaccines Market Size is valued at 239.91 Million in 2023 and is predicted to reach 436.26 Million by the year 2031 at a 8.1 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The rise in severe diseases such as cancer, diabetes, and autoimmune disorders has increased the demand for therapeutic proteins. These proteins are used for treating conditions where traditional small-molecule drugs are ineffective.
- There is a growing awareness between both healthcare professionals and the general public about the benefits of therapeutic proteins and vaccines in preventing and treating diseases. This increased awareness is driving demand for these products.
- North America dominated the market and accounted for a global revenue share in 2023.
- The manufacturing of therapeutic proteins and oral vaccines often involves complex processes, such as cell culture, purification, and formulation. Ensuring consistent product quality and scalability can be challenging, leading to production delays and cost overruns.
Therapeutic proteins are genetically engineered proteins that have a wide range of treatment applications. Therapeutic proteins are mainly prepared for pharmaceutical use. Oral vaccines are biologically prepared products, which are used in treating or preventing various infectious diseases. The increasing number of pharmaceutical drug developments or innovations is expected to drive the growth of the therapeutic protein and oral vaccine market in the near future.
Major driving factors of the therapeutic proteins and oral vaccines market are the increasing need for therapeutic proteins and oral vaccines, high prevalence of cancer diseases, rising number of clinical trials, increasing investments by key players for the development of promising therapies. Furthermore, advanced medical technologies, growth in the population, and a growing number of health-conscious people are enhancing the growth of the therapeutic proteins and oral vaccines market. However, the high price of devices, complex procedures, lack of strict government laws are restraining the growth of this market.
Competitive Landscape
Some Major Key Players In The Therapeutic Proteins and Oral Vaccines Market:
- Abbott Laboratories,
- Amgen, Inc.,
- Biogen, Inc.,
- Eily, Lilly, and Company,
- Hoffmann-La Roche,
- Johnson and Johnson,
- Merck & Co.,
- Novo Nordisk,
- Pfizer, Inc.,
- Sanofi S.A.,
- Serum Institute of India Pvt. Ltd.,
- Emergent Biosolutions Inc.,
- TransAlgae,
- MigVax Ltd,
- Lumen Bioscience, Inc.,
Market Segmentation
The therapeutic proteins and oral vaccines market is segmented into Drug Class, Distribution Channels, Applications, and regions. The Drug Class segment is further bifurcated into Therapeutic Proteins and Oral Vaccines. Therapeutic Proteins are subdivided into Therapeutic Proteins, Growth Factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Coagulation Factors, and Other Therapeutic Proteins. While, Oral Vaccines are subdivided into Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Other Oral Vaccines. In the coming future, therapeutic proteins will be in high scope due to their effective and fast results and rise in therapy innovations. By Distribution Channels, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies will upscale the market of therapeutic proteins and oral vaccines over the forecast period. In terms of Applications, the market can be divided into Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Other Applications. Oncology and Infectious diseases are the fastest-growing segments of this market due to the increasing prevalence of cancer and infectious diseases. Based on the region, the therapeutic proteins and oral vaccines market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America followed by Europe holds the maximum share of this market due to increased research and development expenditure, presence of significant market players and fast adaption of advanced technologies.
Recent Developments:
- In April 2024, Bharat Biotech along with Bilthoven Biologicals B.V. (BBio), a fully owned subsidiary of Serum Institute of India Pvt. Ltd. with headquarters in the Netherlands, announced a partnership to enhance the production and supply security of oral polio vaccines (OPV).By means of this partnership, BBIL and BBio shall acquire collectively the necessary regulatory approvals and licenses to manufacture OPVs for global distribution in India from medicinal substances produced at Bilthoven Biologicals in the Netherlands.
Therapeutic Proteins and Oral Vaccines Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 239.91 Million |
|
Revenue Forecast In 2031 |
USD 436.26 Million |
|
Growth Rate CAGR |
CAGR of 8.1 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Drug Class, By Distribution Channel, By Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc., TransAlgae, MigVax Ltd, Lumen Bioscience, Inc., and Other Prominent Players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
